Long term inhibition of complement C1s in patients with cold agglutinin disease: results from a named patient program

被引：0
|
作者：
Jilma, B. [1 ]
Gelbenegger, G. [1 ]
Derhaschnig, U. [1 ]
Sillaber, C. [2 ]
D'Sa, S. [3 ]
Fillitz, M. [4 ]
Schenk, T. [5 ]
Gilbert, J. [6 ]
Cartwright, R. [7 ]
Jaeger, U. [2 ]
机构：
[1] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria
[2] Med Univ Vienna, Dept Internal Med 1, Div Hematol, Vienna, Austria
[3] Univ Coll London Hosp NHS Fdn Trust, UCLH Ctr Waldenstroms Macroglobulinaemia & Relate, London, England
[4] Hanusch Hosp, Dept Internal Med, Vienna, Austria
[5] Univ Klinikum St Polten, Dept Internal Med, St Polten, Austria
[6] Band Therapeut, Lexington, MA USA
[7] Worthing Hosp Western Sussex Hosp, Worthing, England
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V46
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [1] Long term inhibition of complement C1s in patients with cold agglutinin disease: Results from a named patient program
    Gelbenegger, Georg
    Schoergenhofer, Christian
    Sillaber, Christian
    D'Sa, Shirley
    Fillitz, Michael
    Schenk, Thomas
    Gilbert, James C.
    Cartwright, Ronwyn
    Jilma, Bernd
    Jaeger, Ulrich
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 : S446 - S446
  • [2] Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program
    Gelbenegger, Georg
    Schoergenhofer, Christian
    Derhaschnig, Ulla
    Buchtele, Nina
    Sillaber, Christian
    Fillitz, Michael
    Schenk, Thomas M.
    D'Sa, Shirley
    Cartwright, Ronwyn
    Gilbert, James C.
    Jilma, Bernd
    Jaeger, Ulrich
    [J]. BLOOD ADVANCES, 2020, 4 (06) : 997 - 1005
  • [3] Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study
    Roth, Alexander
    Barcellini, Wilma
    D'Sa, Shirley
    Miyakawa, Yoshitaka
    Broome, Catherine M.
    Michel, Marc
    Kuter, David J.
    Jilma, Bernd
    Tvedt, Tor Henrik Anderson
    Lin, Stella
    Jiang, Xiaoyu
    Reuter, Caroline
    Hobbs, William
    Berentsen, Sigbjorn
    [J]. BLOOD, 2019, 134
  • [4] INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FROM THE PHASE 3 CARDINAL STUDY
    Roeth, A.
    Barcellini, W.
    D'Sa, S.
    Miyakawa, Y.
    Broome, C. M.
    Michel, M.
    Kuter, D. J.
    Jilma, B.
    Tvedt, T. H. Anderson
    Lin, S.
    Jiang, X.
    Reuter, C.
    Hobbs, W.
    Berentsen, S.
    [J]. HAEMATOLOGICA, 2020, 105 : S38 - S38
  • [5] Results from the phase 3 Cardinal study part A: Inhibition of complement C1s with Sutimlimab in patients with Cold Agglutinin Disease (CAD)
    Roeth, A.
    Barcellini, W.
    Sa, D. S.
    Miyakawa, Y.
    Broome, C. M.
    Michel, M.
    Kuter, D. J.
    Jilma, B.
    Tvedt, Anderson T. H.
    Lin, S.
    Jiang, X.
    Reuter, C.
    Hobbs, W.
    Berentsen, S.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 177 - 177
  • [6] Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease
    Roeth, Alexander
    Barcellini, Wilma
    D'Sa, Shirley
    Miyakawa, Yoshitaka
    Broome, Catherine M.
    Michel, Marc
    Kuter, David J.
    Jilma, Bernd
    Tvedt, Tor Henrik Anderson
    Weitz, Ilene C.
    Yoo, Ronnie
    Jayawardene, Deepthi
    Vagge, Deepthi S.
    Kralova, Katarina
    Shafer, Frank
    Wardecki, Marek
    Lee, Michelle
    Berentsen, Sigbjorn
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (08) : 1246 - 1253
  • [7] INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): INTERIM RESULTS OF THE PHASE 3 CARDINAL STUDY LONG -TERM FOLLOW-UP
    Barcellinia, W.
    Roeth, A.
    D'Sa, S.
    Miyakawa, Y.
    Broome, C. M.
    Michel, M.
    Kuter, D. J.
    Jilma, B.
    Tvedt, T. H. Anderson
    Weitz, I. C.
    Patel, P.
    Jiang, X.
    Reuter, C.
    Su, J.
    Shafer, F.
    Lee, M.
    Hobbsb, W.
    Berentsen, S.
    [J]. HAEMATOLOGICA, 2021, 106 (10) : 107 - 107
  • [8] Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Interim Results of the Phase 3 Cardinal Study Long-Term Follow-up
    Roth, Alexander
    Barcellini, Wilma
    D'Sa, Shirley
    Miyakawa, Yoshitaka
    Broome, Catherine M.
    Michel, Marc
    Kuter, David J.
    Jilma, Bernd
    Tvedt, Tor Henrik Anderson
    Weitz, Ilene C.
    Patel, Parija
    Jiang, Xiaoyu
    Reuter, Caroline
    Su, Jun
    Shafer, Frank
    Lee, Michelle
    Hobbs, William
    Berentsen, Sigbjorn
    [J]. BLOOD, 2020, 136
  • [9] Interim results of the phase 3 CARDINAL study long-term follow-up: Inhibition of complement C1s with sutimlimab in patients with Cold Agglutinin Disease (CAD)
    Roeth, A.
    Barcellini, W.
    D'Sa, S.
    Miyakawa, Y.
    Broome, C.
    Michel, M.
    Kuter, D.
    Jilma, B.
    Tvedt, T. H. A.
    Weitz, I. C.
    Patel, P.
    Jiang, X.
    Reuter, C.
    Su, J.
    Shafer, F.
    Lee, M.
    Hobbs, W.
    Berentsen, S.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 169 - 170
  • [10] Long-term efficacy and safety of continued complement C1s inhibition with sutimlimab in cold agglutinin disease: CADENZA study Part B
    Roeth, Alexander
    Berentsen, Sigbjorn
    Barcellini, Wilma
    D'Sa, Shirley
    Jilma, Bernd
    Michel, Marc
    Weitz, Ilene C.
    Yamaguchi, Masaki
    Nishimura, Jun-ichi
    Vos, Josephine M. I.
    Cid, Joan
    Storek, Michael
    Wong, Nancy
    Yoo, Ronnie
    Jayawardene, Deepthi
    Srivastava, Shruti
    Wardecki, Marek
    Shafer, Frank
    Lee, Michelle
    Broome, Catherine M.
    [J]. ECLINICALMEDICINE, 2024, 74
12345